Rolf Müller

Prof. Dr. Rolf Müller

Center for Tumor Biology and Immunology, Philipps University, 35043 Marburg, Germany
orcid

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1995 in Gene
Verified
Journal Article
Closed access
DMDominik Mumberg
Dominik Mumberg
RMRolf Müller
Rolf Müller
MFMartin Funk
Martin Funk

20 December 1984 in Nature
Verified
Journal Article
Closed access
PDF file
RMRolf Müller
Rolf Müller
RBRodrigo Bravo
Rodrigo Bravo
JBJean Burckhardt
Jean Burckhardt
TCTom Curran
Tom Curran

1 August 1996 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JLJosée N. Lavoie
Josée N. Lavoie
GLGilles L'ALlemain
Gilles L'ALlemain
ABAnne Brunet
Anne Brunet
RMRolf Müller
Rolf Müller
JPJacques Pouysségur
Jacques Pouysségur
We have previously shown that the persistent activation of p42/p44(MAPK) is required to pass the G1 restriction point in fibroblasts (Pagès, G., Lenormand, P., L'Allemain, G., Chambard, J. C., Meloche, S., and Pouysségur, J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8319-8323) and postulated that MAPKs control the activation of G1 cyclin-dependent complexes. We examined the mitogen-dependent induction of cyclin D1 expression, one of the earliest cell cycle-related events to occur during the G0/G1 to S-phase transition, as a potential target of MAPK regulation. Effects exerted either by the p42/p44(MAPK) or the p38/HOGMAPK cascade on the regulation of cyclin D1 promoter activity or cyclin D1 expression were compared in CCL39 cells, using a co-transfection procedure. We found that inhibition of the p42/p44(MAPK) signaling by expression of dominant-negative forms of either mitogen-activated protein kinase kinase 1 (MKK1) or p44(MAPK), or by expression of the MAP kinase phosphatase, MKP-1, strongly inhibited expression of a reporter gene driven by the human cyclin D1 promoter as well as the endogenous cyclin D1 protein. Conversely, activation of this signaling pathway by expression of a constitutively active MKK1 mutant dramatically increased cyclin D1 promoter activity and cyclin D1 protein expression, in a growth factor-independent manner. Moreover, the use of a CCL39-derived cell line that stably expresses an inducible chimera of the estrogen receptor fused to a constitutively active Raf-1 mutant (DeltaRaf-1:ER) revealed that in absence of growth factors, activation of the Raf > MKK1 > p42/p44MAPK cascade is sufficient to fully induce cyclin D1. In marked contrast, the p38(MAPK) cascade showed an opposite effect on the regulation of cyclin D1 expression. In cells co-expressing high levels of the p38(MAPK) kinase (MKK3) together with the p38(MAPK), a significant inhibition of mitogen-induced cyclin D1 expression was observed. Furthermore, inhibition of p38(MAPK) activity with the specific inhibitor, SB203580, enhanced cyclin D1 transcription and protein level. Altogether, these results support the notion that MAPK cascades drive specific cell cycle responses to extracellular stimuli, at least in part, through the modulation of cyclin D1 expression and associated cdk activities.

1 January 1994 in Nucleic Acids Research
Verified
Journal Article
Closed access
DMDominik Mumberg
Dominik Mumberg
RMRolf Müller
Rolf Müller
MFMartin Funk
Martin Funk

1 April 1983 in Cell
Verified
Journal Article
Closed access
CBCharles Van Beveren
Charles Van Beveren
FSFlip van Straaten
Flip van Straaten
TCTom Curran
Tom Curran
RMRolf Müller
Rolf Müller
IVInder M. Verma
Inder M. Verma

14 October 1982 in Nature
Verified
Journal Article
Closed access
RMRolf Müller
Rolf Müller
DSDennis J. Slamon
Dennis J. Slamon
JTJoanne M. Tremblay
Joanne M. Tremblay
MCMartin J. Cline
Martin J. Cline
IVInder M. Verma
Inder M. Verma